Drug Database · Clinicians

Bismuth subsalicylate

Brands (1) BismosydShow all

US brand (reference label): Digestive Relief; not a Philippine-registered brand.

Bismuth US FDA class
Anti-diarrheal PH FDA category

OTC · Over-the-counter1 PH product
Dispensing: Over-the-counter (OTC) Last updated: Audience: Licensed health professionals
Label text on this page: US FDA-approved label via DailyMed/openFDA, set ID 5538d56a-b258-4260-b51b-f5131bd76885, version date November 3, 2026 (Digestive Relief · SAFEWAY). Reproduced verbatim. Philippine-approved indications and doses may differ: check the PH package insert.

Use: Labeled indications

  • Uses relieves: ▪ travelers’ diarrhea ▪ diarrhea upset stomach due to overindulgence in food and drink, including: ■ heartburn ■ indigestion ■ nausea ■ gas ■ belching ■ fullness
US FDA label
Full indications and usage US FDA label

Uses relieves: ▪ travelers’ diarrhea ▪ diarrhea upset stomach due to overindulgence in food and drink, including: ■ heartburn ■ indigestion ■ nausea ■ gas ■ belching ■ fullness

Dosing: Adult

Dosage and administration (US label) US FDA label

Directions ▪ swallow with water, do not chew ▪ adults and children 12 years and older: 2 caplets every 1/2 to 1 hour as needed ▪ do not exceed 8 doses (16 caplets) in 24 hours ▪ use until diarrhea stops but not more than 2 days ▪ children under 12 years: ask a doctor ▪ drink plenty of clear fluids to help prevent dehydration caused by diarrhea

Dosing: Altered kidney function

No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.

Kidney-specific guidance from renalcarematters.com: in preparation.

Dosage forms

Philippines

  • Chewable tablet: 262 mg

Registered products in the Philippines

1 product registered with the Food and Drug Administration (FDA) Philippines list Bismuth subsalicylate as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.

Verify on PH FDA portal

Philippine FDA-registered products for Bismuth subsalicylate
Package insert
BismosydBismuth Subsalicylate
262 mg Chewable Tablet (Cherry Flavor)Alu / PVC Clear, Colorless Blister x 6's (Box of 60's)
OTC
Sydenham Laboratories, Inc.Philippines
—
DRP-11110
Feb 9, 2027

Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.

Warnings/Precautions

Warnings and precautions (US label) US FDA label

Reye's syndrome: Children and teenagers who have or are recovering from chicken pox or flu-like symptoms should not use this product. When using this product, if changes in behavior with nausea and vomiting occur, consult a doctor because these symptoms could be an early sign of Reye's syndrome, a rare but serious illness.

Allergy alert: Contains salicylate. Do not take if you are

  • allergic to salicylates (including aspirin)
  • taking other salicylate products. Do not use if you have
  • an ulcer
  • a bleeding problem
  • bloody or black stool Ask a doctor before use if you have
  • fever
  • mucus in the stool Ask a doctor or pharmacist before use if you are taking any drug for
  • anticoagulation (thinning the blood)
  • diabetes
  • gout
  • arthritis When using this product a temporary but harmless darkening of the stool and/or tongue may occur. Stop use and ask a doctor if
  • symptoms get worse or last more than 2 days
  • ringing in the ears or loss of hearing occurs
  • diarrhea lasts more than 2 days If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center immediately at 1-800-222-1222

Formulary and pricing (Philippines)

Check availability

Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.

References

  1. U.S. Food and Drug Administration. Digestive Relief · SAFEWAY [US FDA-approved label, version 7, November 3, 2026]. Via DailyMed/openFDA. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5538d56a-b258-4260-b51b-f5131bd76885
  2. Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph

This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.

For health professionals. This page is a reference compiled from public regulatory sources for licensed health professionals in the Philippines. Verify every product detail against the current Philippine package insert and the FDA Philippines registration record. Information here is not a substitute for clinical judgment and does not replace the prescribing information approved for the specific product you dispense or prescribe.

Last updated: .